Clinical Trial Update: Tolerability of ALK Tree Tablet [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the tolerability of ALK Tree Tablet for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ALK Tree Tablet

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergy | Phase 1 | Status: COMPLETED